J 2019

Accuracy of Colon Capsule Endoscopy for Colorectal Neoplasia Detection in Individuals Referred for a Screening Colonoscopy

VOSKA, Michal, Miroslav ZAVORAL, Tomas GREGA, Ondřej MÁJEK, Jan MARTINEK et. al.

Základní údaje

Originální název

Accuracy of Colon Capsule Endoscopy for Colorectal Neoplasia Detection in Individuals Referred for a Screening Colonoscopy

Autoři

VOSKA, Michal (203 Česká republika), Miroslav ZAVORAL (203 Česká republika), Tomas GREGA (203 Česká republika), Ondřej MÁJEK (203 Česká republika, domácí), Jan MARTINEK (203 Česká republika), Ilja TACHECI (203 Česká republika), Marek BENES (203 Česká republika), Gabriela VOJTECHOVA (203 Česká republika), Pavel DRASTICH (203 Česká republika), Jan BURES (203 Česká republika), Julius SPICAK (203 Česká republika), Barbora BUČKOVÁ (703 Slovensko, domácí), Ondřej NGO (203 Česká republika, domácí) a Stepan SUCHANEK (203 Česká republika, garant)

Vydání

Gastroenterology Research and Practice, New York, Hindawi Publishing Corporation, 2019, 1687-6121

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.806

Kód RIV

RIV/00216224:14110/19:00108525

Organizační jednotka

Lékařská fakulta

UT WoS

000486404300001

Klíčová slova anglicky

Colon Capsule Endoscopy; Colorectal Neoplasia Detection; Screening

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 16. 10. 2019 15:49, Mgr. Tereza Miškechová

Anotace

V originále

Backround. Capsule colonoscopy might present an alternative to colonoscopy for colorectal neoplasia screening. Aim. To assess the accuracy of second-generation capsule colonoscopy (CCE2) for colorectal neoplasia detection compared with conventional colonoscopy (CC). Methods. From 2011-2015, we performed a multicenter, prospective, cross-over study evaluating the use of CCE2 as a possible colorectal cancer (CRC) screening test based on the assessment of the method's characteristics (accuracy) and safety and patient acceptance of the routine. Enrolled participants fulfilled the CRC screening population criteria if they were asymptomatic, were older than 50, and had no personal or familial history of colorectal neoplasia. The primary outcome was accuracy for the detection of polyps >= 6 mm. Secondary outcomes were accuracy for all polyps, polyps >= 10 mm, adenomas >= 10 mm, and cancers, the quality of bowel cleansing, safety, and CCE2 acceptability by the screening population. Results. A total of 236 individuals were examined; 11 patients (5%) were excluded. Therefore, 225 subjects (95%) were considered in the intention-to-screen (ITS) group. A total of 201 patients (89%) completed both examinations successfully (per protocol group). In the ITS group, polyps were diagnosed during CC in 114 subjects (51%); polyps >= 6 mm, polyps >= 10 mm, and adenomas >= 10 mm were diagnosed in 34 (15%), 16 (7%), and 11 (5%) patients, respectively. The sensitivity of CCE2 for polyps >= 6 mm, polyps >= 10 mm, and adenomas >= 10 mm was 79% (95% confidence interval (CI): 62-91%), 88% (95% CI: 62-98%), and 100% (95% CI: 72-100%), respectively. Conclusion. Second-generation capsule colonoscopy is a safe, noninvasive, and sensitive method for colorectal neoplasia detection although CC remains the preferred method for considerable proportion of subjects. CCE2 may therefore be accepted as the primary screening test for colorectal cancer screening.

Návaznosti

NV16-29614A, projekt VaV
Název: Porovnání účinnosti kolonické kapslové endoskopie a optické kolonoskopie u osob s pozitivním imunochemickým testem na okultní krvácení do stolice